Latest Breaking News On - Catalym gmb - Page 1 : comparemela.com

CatalYm Presents Positive Phase 2a Outcome for Visugromab in Advanced NSCLC and Urothelial Cancer at the ESMO Immuno-Oncology Congress 2023

CatalYm Presents Positive Phase 2a Outcome for Visugromab in Advanced NSCLC and Urothelial Cancer at the ESMO Immuno-Oncology Congress 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Spain
Geneva
Genè
Switzerland
Ignacio-melero
Phil-lhuillier
Catalym-gmb
Oncology-congress
Department-of-immunology
International-coordinating-investigator-prof
European-society-for-medical-oncology
Trophic-communications

CatalYm Presents Data at SITC 2023 Annual Meeting Further Unraveling GDF-15-mediated Inhibition of T Cell Adhesion and a New Combination Approach for Visugromab with Bispecific T-Cell Engagers

CatalYm Presents Data at SITC 2023 Annual Meeting Further Unraveling GDF-15-mediated Inhibition of T Cell Adhesion and a New Combination Approach for Visugromab with Bispecific T-Cell Engagers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San-diego
California
United-states
Phil-lhuillier
Christine-schuberth-wagner
Catalym-gmb
Trophic-communications
Society-for-immunotherapy-of-cancer
Chief-scientific-officer
Central-mediator
T-cell-engager
Ted-human-effector-cell-relocation

CatalYm commences Dosing in a Phase 2 Study with Visugromab in Combination with Neoadjuvant Immunotherapy in Treatment-naive Muscle Invasive Bladder Cancer Patients

CatalYm commences Dosing in a Phase 2 Study with Visugromab in Combination with Neoadjuvant Immunotherapy in Treatment-naive Muscle Invasive Bladder Cancer Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Italy
Milan
Lombardia
Catalym-gmb
Phil-lhuilier
Andrea-necchi
Phil-lhuillier
Trophic-communications
Genitourinary-medical-oncology
Raffaele-hospital
Principal-investigator
Phill-huillier

CatalYm Presents Data at ESMO 2023 Expanding GDF-15's Role in Checkpoint Therapy Resistance by Inhibition of Myeloid Immune Cell Activation

CatalYm Presents Data at ESMO 2023 Expanding GDF-15's Role in Checkpoint Therapy Resistance by Inhibition of Myeloid Immune Cell Activation
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Spain
Madrid
Phil-lhuilier
Catalym-gmb
Christine-schuberth-wagner
Nature-communications
Trophic-communications
European-society-for-medical-oncology
European-society
Medical-oncology
Chief-scientific-officer
Ted-human-effector-cell-relocation